NLA to kick off familial hypercholesterolemia awareness campaign
The National Lipid Association is kicking off a public health campaign about familial hypercholesterolemia on May 18. The start of the campaign, ?FH: It?s Relative?Know Your Family Cholesterol History,? coincides with NLA?s Annual Scientific Sessions in New York City.
The National Lipid Association (NLA) is kicking off a public health campaign about familial hypercholesterolemia (FH) on May 18. The start of the campaign, “FH: It’s Relative-Know Your Family Cholesterol History,” coincides with NLA’s Annual Scientific Sessions in New York City.
The NLA and its foundation believe the campaign is needed because so few people realize that they or their relatives need to get checked for FH, which affects nearly 700,000 Americans.
“It is the most common inherited genetic disease that we can treat in the U.S. It all stems from knowing if you have it,” said Jamie Underberg, MD, clinical assistant professor of medicine at NYU Medical School and director of the Bellevue Hospital Lipid Clinic.
Dr Underberg and other members of the NLA want patients with high cholesterol and heart disease to be checked for FH, and ask their relatives to be screened as well. “It is a simple blood test and a trip to the doctor. Is there anyone in your family that has had early heart disease? If so, the next step is getting family members screened for FH,” Underberg said.
The NLA is urging pharmacists, registered dietitians, and other health professionals to spread the word about the FH campaign. To prepare for the “It’s Relative” campaign, 6 papers on FH from the NLA will be published in the May 2011 issue of the Journal of Clinical Lipidology.
For information on the campaign, visit www.lipid.org or refer patients to www.learnyourlipids.com.
David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2
July 1st 2020In this week's episode of Tuning Into The C-Suite podcast, MHE's Briana Contreras chatted with David Calabrese, R.Ph, MHP, who is senior vice president and chief pharmacy officer of pharmacy care services company, OptumRx. David is also a member of Managed Healthcare Executives’ Editorial Advisory Board. During the discussion, he shared the OptumRx Quarter 2 Drug Pipeline Insights Report of 2020. Some of the information shared includes the three notable drugs currently being reviewed or those that have been recently approved by the FDA. Also discussed were any interesting industry trends to watch for.
Listen
